Cargando…
The Synthetic Plasmodium falciparum Circumsporozoite Peptide PfCS102 as a Malaria Vaccine Candidate: A Randomized Controlled Phase I Trial
BACKGROUND: Fully efficient vaccines against malaria pre-erythrocytic stage are still lacking. The objective of this dose/adjuvant-finding study was to evaluate the safety, reactogenicity and immunogenicity of a vaccine candidate based on a peptide spanning the C-terminal region of Plasmodium falcip...
Autores principales: | Audran, Régine, Lurati-Ruiz, Floriana, Genton, Blaise, Blythman, Hildur E., Ofori-Anyinam, Opokua, Reymond, Christophe, Corradin, Giampietro, Spertini, François |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2749339/ https://www.ncbi.nlm.nih.gov/pubmed/19798415 http://dx.doi.org/10.1371/journal.pone.0007304 |
Ejemplares similares
-
Novel birch pollen specific immunotherapy formulation based on contiguous overlapping peptides
por: Pellaton, Céline, et al.
Publicado: (2013) -
PFCs and Cholesterol: A Sticky Connection
por: Tillett, Tanya
Publicado: (2010) -
A Malaria Vaccine That Elicits in Humans Antibodies Able to Kill Plasmodium
falciparum
por: Druilhe, Pierre, et al.
Publicado: (2005) -
Endogenous leptin promotes autophagy in EBSS-induced PFCs
por: Jiao, Deling, et al.
Publicado: (2019) -
Rapid clearance of malaria circumsporozoite protein (CS) by hepatocytes
Publicado: (1994)